[go: up one dir, main page]

FR2420541A1 - Glycoproteine-hgi capable de stimuler la proliferation et la differentiation des granulocytes humains, sa preparation et medicaments de la leucopenie en contenant - Google Patents

Glycoproteine-hgi capable de stimuler la proliferation et la differentiation des granulocytes humains, sa preparation et medicaments de la leucopenie en contenant

Info

Publication number
FR2420541A1
FR2420541A1 FR7906887A FR7906887A FR2420541A1 FR 2420541 A1 FR2420541 A1 FR 2420541A1 FR 7906887 A FR7906887 A FR 7906887A FR 7906887 A FR7906887 A FR 7906887A FR 2420541 A1 FR2420541 A1 FR 2420541A1
Authority
FR
France
Prior art keywords
reaction
glycoprotein
stimulating
proliferation
differentiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7906887A
Other languages
English (en)
Other versions
FR2420541B1 (fr
Inventor
Fumimaro Takaku
Katsuhiro Ogasa
Morio Kuboyama
Minoru Saito
Nobuya Yanai
Masayuki Nishida
Satoshi Funakoshi
Muneo Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morinaga Milk Industry Co Ltd
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53031999A external-priority patent/JPS6030291B2/ja
Priority claimed from JP53080695A external-priority patent/JPS6030293B2/ja
Priority claimed from JP53080694A external-priority patent/JPS6030292B2/ja
Priority claimed from JP53118203A external-priority patent/JPS6030294B2/ja
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of FR2420541A1 publication Critical patent/FR2420541A1/fr
Application granted granted Critical
Publication of FR2420541B1 publication Critical patent/FR2420541B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1875Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04Heat
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Glycoprotéine isolée de l'urine de sujets normaux, qui agit sur les cellules granulopoïétiques de la moelle de l'os humain, stimulant ainsi la prolifération et la différentiation de ces cellules pour former des granulocytes. La glycoprotéine produit une couleur caractéristique des saccharides dans la réaction à l' alpha -naphthol-acide sulfurique, dans la réaction à l'indol-acide sulfurique, dans la réaction à l'anthrone-acide sulfurique et dans la réaction au phénol-acide sulfurique, et une couleur caractéristique des liaisons amino et polypeptides dans la réaction de Lowry-Folin et dans la réaction à ninhydrine après hydrolyse par l'acide chlorhydrique Application en médecine.
FR7906887A 1978-03-20 1979-03-19 Glycoproteine-hgi capable de stimuler la proliferation et la differentiation des granulocytes humains, sa preparation et medicaments de la leucopenie en contenant Granted FR2420541A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP53031999A JPS6030291B2 (ja) 1978-03-20 1978-03-20 人顆粒球の分化増殖を促進するhgi糖蛋白質、hgi糖蛋白質の製造法及びhgi糖蛋白質を含有する白血球減少症治療剤
JP53080695A JPS6030293B2 (ja) 1978-07-03 1978-07-03 人顆粒球の分化増殖を促進する加熱処理hgigp及びhgigpの加熱処理方法
JP53080694A JPS6030292B2 (ja) 1978-07-03 1978-07-03 人顆粒球の分化増殖を促進する加熱処理hgigp及びhgigpの加熱処理法
JP53118203A JPS6030294B2 (ja) 1978-09-26 1978-09-26 人顆粒球の分化増殖を促進する糖蛋白質を含有する分画の加熱処理方法

Publications (2)

Publication Number Publication Date
FR2420541A1 true FR2420541A1 (fr) 1979-10-19
FR2420541B1 FR2420541B1 (fr) 1983-05-06

Family

ID=27459534

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7906887A Granted FR2420541A1 (fr) 1978-03-20 1979-03-19 Glycoproteine-hgi capable de stimuler la proliferation et la differentiation des granulocytes humains, sa preparation et medicaments de la leucopenie en contenant

Country Status (8)

Country Link
AT (1) AT362392B (fr)
AU (1) AU523077B2 (fr)
CH (1) CH640865A5 (fr)
DE (1) DE2910745A1 (fr)
FR (1) FR2420541A1 (fr)
GB (1) GB2016477B (fr)
NL (1) NL190759C (fr)
SE (1) SE451844B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342828A (en) * 1979-07-20 1982-08-03 Morinaga Milk Industry Co., Ltd. Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
JPS57144225A (en) * 1981-03-04 1982-09-06 Tadao Kokubu Antigenetic preparation for treating nonspecific allergic diseases and its preparation
JPH0753667B2 (ja) * 1985-08-09 1995-06-07 新技術開発事業団 骨髄移植療法補助剤
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
EP0246322B1 (fr) * 1985-11-27 1992-08-26 Genetics Institute, Inc. Traitement de maladies du type du sida
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor

Also Published As

Publication number Publication date
AU4519779A (en) 1979-09-27
GB2016477B (en) 1982-08-25
SE451844B (sv) 1987-11-02
DE2910745A1 (de) 1979-10-04
DE2910745C2 (fr) 1988-06-23
AT362392B (de) 1981-05-11
NL190759B (nl) 1994-03-01
GB2016477A (en) 1979-09-26
FR2420541B1 (fr) 1983-05-06
NL7902178A (nl) 1979-09-24
AU523077B2 (en) 1982-07-08
SE7902372L (fr) 1979-09-21
NL190759C (nl) 1994-08-01
ATA208479A (de) 1980-10-15
CH640865A5 (de) 1984-01-31

Similar Documents

Publication Publication Date Title
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
Charbon et al. Augmentation of arterial hepatic and renal flow by extracted and synthetic parathyroid hormone
NO892985L (no) Nytt, fast og poroest enhetselement omfattende mikropartikler og/eller nanopartikler og fremgangsmaate for fremstilling derav.
FR2448347A1 (fr) Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques
CA2163256A1 (fr) Vecteurs adenoviraux d'origine animale et utilisation en therapie genique
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
BR0209177A (pt) Anticorpo especìfico a tumor recombinante e uso do mesmo
FR2604357B1 (fr) Composition pharmaceutique et cosmetique anti-acneique
BR9810378A (pt) Composto,uso do mesmo, composição farmacêutica, e, processos de tratar a diabete do tipo i ou do tipo ii, de tratar a hiperglicemia, e de diminuir a glicose do sangue em um mamìfero
AU7601887A (en) Expression products of human papilloma virus type 18, antibodies specific to these proteins, and diagnostic aids containing these antibodies or corresponding DNA
CO5690564A2 (es) Medicamento para tratar tejido de miocardio infartado que comprende mioblastos oseos de mamiferos geneticamente modoficados para expresar la proteina sdf-1 de mamifero
CA2062969A1 (fr) Proteine cofacteur de la membrane humaine produite par recombinaison
FR2420541A1 (fr) Glycoproteine-hgi capable de stimuler la proliferation et la differentiation des granulocytes humains, sa preparation et medicaments de la leucopenie en contenant
FR2617047B1 (fr) Composition de gelatine resistant au tannage, capsules a base de cette composition et leur application pharmaceutique, notamment au fenofibrate
DE59309044D1 (de) Parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
PT86144A (en) Porocess for the preparation of a protein having similar activity to g-tsf human factor and of pharmaceutical compositions therewith
BE900012A (fr) Nouveau peptide.
Gurin Carbohydrates of the gonadotropic hormones
WO1999042127A3 (fr) Peptides derives de recepteurs agissant en tant que modulateurs de l'activite de ces recepteurs
BE902055A (fr) Preparations pharmaceutiques.
KR880002535A (ko) 약제로서의 15-데옥시스퍼구알린의 용도
El Mauhoub et al. “Ricin syndrome”. A possible new teratogenic syndrome associated with ingestion of castor oil seed in early pregnancy: A case report
JPH0645524B2 (ja) 皮膚外用剤
Wright et al. Digestion of protein in the alimentary canal.
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique

Legal Events

Date Code Title Description
ST Notification of lapse